- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
+0.38| Last Update: 05/17/13 - 4:01 PM EDT |
| Volume: 1,671,164 |
| YTD Performance: 31.44% |
| Open: $39.80 |
| Previous Close: $39.50 |
| 52 Week Range: $27.72 - $40.02 |
| Oustanding Shares: 186,643,937 |
| Market Cap: 7,372,435,512 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.69 | $0.69 | $2.78 | $2.80 |
| Number of Analysts | 21 | 20 | 21 | 20 |
| High Estimate | $0.72 | $0.73 | $2.89 | $3.31 |
| Low Estimate | $0.64 | $0.63 | $2.59 | $2.45 |
| Prior Year | $0.76 | $0.69 | $2.78 | $2.78 |
| Growth Rate (Year over Year) | -8.90% | 0.72% | 0.15% | 0.47% |
Comerica downgraded at BairdCMA was downgraded from Neutral to Underperform, Robert Baird said. $33 price target. Valuation call, as the stock is up 24% year-to-date.
Comerica estimates, target boosted at Credit SuisseShares of CMA now seen reaching $36, according to Credit Suisse. Estimates also upped, as the company is keeping a tight lid on costs. Neutral rating.
This strategy will add high current yield and income growth to your portfolio.
Since its inception, this fund has more than doubled the overall market return with its unique approach to bank stock investing.
Comerica downgraded at CitigroupCMA was downgraded to Sell from Neutral. $31 price target. Valuation stretched.
We are about to see real lending in this country.
Comerica downgraded at BernsteinCMA was downgraded from Market Perform to Underperform, Bernstein Research said. Valuation call, based on a $27 price target.
We can't discuss banks and energy without looking at Texas.
Comerica numbers raised at JefferiesShares of CMA now seen reaching $35, Jefferies said. Estimates also raised on loan growth. Hold rating.
Comerica estimates, target increased at BMOCMA estimates were raised through 2014, BMO Capital said. Company is seeing better net interest income and has a lower provision forecast. Market Perform rating and new $32 price target.